Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

NCT06828588 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Cancer
Metastatic Cancer
HER2
HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma
HER 2 Low-expressing Breast Cancer

Interventions

DRUG: [68Ga]Ga-ABY-025

Sponsor

Vanderbilt-Ingram Cancer Center